BEUDAMED
    FDA Adverse Event Injury Summary report: N

    FINELINE II

    MDR report key: 3912269 · Received July 3, 2014

    Report

    Report Number
    2124215-2014-11274
    Event Type
    Injury
    Date Received
    July 3, 2014
    Date of Event
    May 12, 2014
    Report Date
    May 12, 2014
    Manufacturer
    CPI - DEL CARIBE
    Product Code
    DTB
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    IA
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    (B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

    Description of Event or Problem · 1

    BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED UNDERSENSING AND HIGH PACING THRESHOLD JUST THREE DAYS AFTER IMPLANT. THE LEAD WAS REPOSITIONED. ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE ABOVE FINDINGS WERE DUE TO MICRODISLODGEMENT. THIS RV LEAD REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    391663 FINELINE II IMPLANTABLE LEAD DTB CPI - DEL CARIBE 4473

    Patients

    Seq Age Sex Outcome Treatment
    1 77 YR Hospitalization| L| R K064| 4473| 4472